title: Schedules of Controlled Substances: Placement of Eluxadoline Into   Schedule IV. Final rule.
abstract: With the issuance of this final rule, the Administrator of the Drug Enforcement Administration places the substance 5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid (eluxadoline), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess) or propose to handle eluxadoline.
mesh_terms: D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D005765:Gastrointestinal Agents / Q000145:classification*; D006801:Humans; D007093:Imidazoles / Q000145:classification*; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000145:classification*; D017465:Receptors, Opioid, delta / Q000037:antagonists & inhibitors; D017450:Receptors, Opioid, mu / Q000819:agonists; D014481:United States
chemical_list: D005765:Gastrointestinal Agents; D007093:Imidazoles; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D010649:Phenylalanine